GlassScriptPhysician profile
Robert Scott Haskins
NPI 1487629390
$2,790.34
in general payments reported to CMS, 2019-2025
38 companies · $699 in 2025
The $699 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $120 · 2022: $364 · 2023: $736 · 2024: $471 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $432.19 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $346.45 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $218.14 | 2022-2025 | |
| Glaxosmithkline, LLC. | $194.45 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Novartis Pharmaceuticals Corporation | $162.94 | 2019-2025 | |
| Exact Sciences Corporation | $146.07 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $145.79 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $143.33 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $127.59 | 2019-2025 | Breztri |
| Abbott Laboratories | $88.50 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $78.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.97 | 2019-2025 | Jardiance |
| Pfizer INC. | $59.14 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $58.06 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.90 | 2020-2024 | Xifaxan, Trulance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $37.60 | 2019-2020 | |
| Corium, LLC | $33.82 | 2023-2024 | Azstarys |
| Pulmonx Corporation | $27.94 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Amgen INC. | $27.54 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $26.71 | 2023-2024 | Rexulti |
| Insulet Corporation | $26.13 | 2025 | Omnipod |
| Dexcom, INC. | $24.60 | 2024 | Dexcom G6 Transmitter |
| Philips North America LLC | $24.33 | 2025 | Holter |
| Astellas Pharma US INC | $23.87 | 2023 | Veozah |
| Seqirus USA INC | $21.97 | 2025 | Flucelvax |
| Cranial Technologies, INC | $20.81 | 2024 | Doc Band |
| Sanofi-Aventis U.S. LLC | $19.32 | 2022 | |
| Aimmune Therapeutics, INC. | $18.17 | 2025 | Zenpep |
| Mirum Pharmaceuticals, INC. | $18.06 | 2025 | Cholbam |
| Ibsa Pharma INC. | $17.90 | 2019 | |
| Daiichi Sankyo INC. | $16.09 | 2020 | |
| Esperion Therapeutics, INC. | $15.20 | 2023 | Nexletol |
| Bioventus LLC | $14.75 | 2019 | |
| Amarin Pharma, INC. | $14.65 | 2019 | |
| Vertiflex, INC. | $13.12 | 2019 | |
| Organon LLC | $12.76 | 2022 | |
| Coopersurgical, INC. | $12.01 | 2019 | |
| Genentech USA, INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Haskins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.